1. Home
  2. MAIA vs CCG Comparison

MAIA vs CCG Comparison

Compare MAIA & CCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • CCG
  • Stock Information
  • Founded
  • MAIA 2018
  • CCG 2014
  • Country
  • MAIA United States
  • CCG China
  • Employees
  • MAIA N/A
  • CCG N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • CCG
  • Sector
  • MAIA Health Care
  • CCG
  • Exchange
  • MAIA Nasdaq
  • CCG Nasdaq
  • Market Cap
  • MAIA 65.9M
  • CCG 66.2M
  • IPO Year
  • MAIA 2022
  • CCG N/A
  • Fundamental
  • Price
  • MAIA $2.13
  • CCG $0.92
  • Analyst Decision
  • MAIA
  • CCG
  • Analyst Count
  • MAIA 0
  • CCG 0
  • Target Price
  • MAIA N/A
  • CCG N/A
  • AVG Volume (30 Days)
  • MAIA 163.9K
  • CCG 342.4K
  • Earning Date
  • MAIA 11-12-2024
  • CCG 08-29-2024
  • Dividend Yield
  • MAIA N/A
  • CCG N/A
  • EPS Growth
  • MAIA N/A
  • CCG N/A
  • EPS
  • MAIA N/A
  • CCG N/A
  • Revenue
  • MAIA N/A
  • CCG $458,246,707.00
  • Revenue This Year
  • MAIA N/A
  • CCG $4.89
  • Revenue Next Year
  • MAIA N/A
  • CCG $2.74
  • P/E Ratio
  • MAIA N/A
  • CCG N/A
  • Revenue Growth
  • MAIA N/A
  • CCG 6.42
  • 52 Week Low
  • MAIA $0.82
  • CCG $0.56
  • 52 Week High
  • MAIA $5.99
  • CCG $10.00
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 33.62
  • CCG 57.23
  • Support Level
  • MAIA $2.42
  • CCG $0.89
  • Resistance Level
  • MAIA $3.48
  • CCG $1.01
  • Average True Range (ATR)
  • MAIA 0.29
  • CCG 0.06
  • MACD
  • MAIA -0.06
  • CCG 0.01
  • Stochastic Oscillator
  • MAIA 1.46
  • CCG 64.10

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

About CCG Cheche Group Inc.

Cheche Group Inc is an insurtech company. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, green auto insurance innovations, etc.

Share on Social Networks: